Monte Rosa Therapeutics Inc (GLUE)

Net Income Growth

-252.96%

Quarterly · Period ending:

GLUE logo

GLUE Net Income Growth

Year-over-year change vs the same period a year earlier

Latest reported-252.96%
GLUE Quarterly Net Income YoY % (-185.36% → -252.96%)
High-resolution chart · PNG

GLUE net income growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Monte Rosa Therapeutics Inc Net Income Growth — Quarterly
Period endingNet Income Growth
-252.9646%
-194.9195%
-443.343%
-13.5043%
59.4358%
246.6623%
140.4096%
31.6047%
13.8382%
0.2185%
-8.0242%
-27.696%
-32.9026%
-33.871%
-31.3225%
-37.7124%
-43.8142%
-94.9495%
-19.2511%
-202.4855%
-243.1208%
-185.3556%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.